Epidemiologic Characteristics of Recent Measles Outbreaks in ROK

Size: px
Start display at page:

Download "Epidemiologic Characteristics of Recent Measles Outbreaks in ROK"

Transcription

1 Epidemiologic Characteristics of Recent Measles Outbreaks in ROK Park Ok Director, Division of VPD control and NIP, KCDC

2 Immunization History for MMR Vaccine 1980 MMR was introduced 1983 MMR was included in NIP dose MMR was recommended by NIP Nationwide huge measles outbreak 2001 MR Supplementary immunization activity 2002 Immunization registry 2005 Web based immunization registry Routine MMR vaccine schedule - MMR 1 at 12-15mo, MMR 2 at 4-6 yr * MMR Vaccine used in Korea

3 Reported Cases of Measles ( Jul) in Korea Cases Imported Import-linked Imported-virus Unknown Under investigation Year Measles incidence: 8.2 cases per 1M population Annual median number: cases [range, cases]

4 Measles Cases in Korea, by Import Status, Jan-July 2014 Cases Epidemiological week Under investigation Imported Import-linked Imported virus Unknown Jul 18, Total Imported Import-associated Endemic Unknown 46 (under investigation) n % Under investigation Imported Import-linked Imported virus Unknown Total

5 Details of Imported measles cases Country Cases No. Details The Philippines 6 Multicultural family Korean returning from international travel Foreign worker International student, Korean China 5 Multicultural family Korean returning from international travel International student, Korean International student, Chinese International worker, Chinese Vietnam 3 Multicultural family Korean returning from international travel Singapore 1 Foreign visitor 1

6 Measles Cases in Korea, by Genotype, Jan-July 2014 Cases B3 D8 H1 Unknown Genotype Genotype n B3 209 D8 7 H1 5 Unknown* 198 Total 419 * Unknown: includes cases under investigation WHO Measles-Rubella Bulletin, Vol 8 Issue 6 (June 2014)

7 Measles Cases in Korea by Age, Jan-July 2014 Cases Age (yr)

8 Measles Cases in Korea by Age Group, Jan-July 2014 Cases Age (yr) Age Group Cases (no.) % ~1yr unvaccinted 1-3yr day care 4-6yr kidergarten 7-12yr yr elementary schooler middle schooler 16-18yr high schooler 19-29yr yr~ college students

9 Measles Cases in Korea, by Age Group and Vaccination History, Jan-July % Never 38% 1 dose Cases % 9% 2 doses Unknown Vaccination History Unknown Age (yr) Vaccination History Unknown Total ~ ~ ~ ~ Subtotal ~3 4~6 7~19 20~ Age (yr)

10 Measles Cases in Korea by Region, Jan-July 2014 Region Confirmed New cases in recent 2 weeks Imported cases Genotype B3 D8 H1 Total Seoul Incheon North Gyeonggi South Gyeonggi Gangwon Daejeon Chungbuk Chungnam Gwangju Jeonbuk Jeonnam Daegu Ulsan Gyeongbuk Busan Gyeongnam Jeju

11 Clinical Manifestations of Measles Cases in Korea, Jan-July 2014 Classic measles (F+R+3C) Non-classic measles Vaccinated Unvaccinated * Unvaccinated cases were more likely to present classic manifestations of measles [OR=3.656 (p <0.000)](among 330 measles cases with available data). Rash: mild, atypical H-F-M dz?, acne?, varicella? Hospitalization rate: 34.8% Pneumonia, encephalitis, death : not reported so far

12 Epidemiological curve of Measles Cases in Korea by Outbreaks, Jan-July 2014 Cases 70 K 대학교 H 중학교 B 중고교 대전, 파주 B 병원 D 고교 가족병원어린이집지역사회학교학원회사 Epidemiological week Daejeon, Mokpo, Gyeonggi(Paju,Bundang,Bucheong) hospital

13 Transmission Chain of Outbreaks in Mokpo and Jeonnam Province F (2) A (48) C (38) G (19) J (19)? B Hospital A Hospital B (31) D (1) M (17 ) E (2) H (6m) I (13m ) C Hospital L (10m ) O (1 ) K (13) 12 persons (12~13) D Mid. School? Family N P (33 ) (6m ) Feb. Mar. Apr. May

14 Transmission Chain of Outbreaks in Health Care Workers of a Hospital Apr May Jun A: 33 B: 32 C: 33 D: 27 Phillippines (Cebu) Deteted during Epi. investigation R/O Mycoplasma infection, R/O Viral infection Worked at emergency room when A pt visited E: 2M F: 30 R/O Sepsis, R/O Meningitis Nurse of the ward where E pt admitted Infective period Hospital visit Exposure Rash onset

15 Transmission Chain of Outbreaks in North Gyeonggi Province C Hospital F (25) G (11m) O (10m) L (14m) P (1) From Philippine C (9m) B Hospital K (13m) M (1) N (10m) A (12) E (11m) B (22m) D (18m) F (9m) G (11m) H (12m) L (13m) H (8m) I (12m) A Hospital Feb. Mar. Apr. May

16 Measles Outbreaks in Health Care Setting, Korea, 2014 Outbreak Name Region Cases No. Import State Genotype Rash onset Duration Age range S Hospital Daejeon 6 Imported virus B days 11M - 31 M Children s hospital J Hospital M Children s hospital N. Gyeonggi (Paju) S. Gyeonggi (Bundang) Jeonnam (Mokpo) 7 Imported (Philippines) B days 8M 12 5 Imported virus B days 10M 1 5 Imported virus B days 6M 1 S ENT clinic Chungbuk 4 Unknown days D Hospital G Hospital S children s hospital N. Gyeonggi (Ilsan) Jeonnam (Mokpo) S. Gyeonggi (Pucheon) 6 Imported (Philippines) B days 9M Imported virus B days Imported virus B ongoing (7.13) 5M 1 G Hospital Incheon 16 Imported virus B days 7M - 30 H Hospital S Hospital S Hospital Jeonnam (Mokpo) Gyeongnam (Andong) S. Gyeonggi (Pucheon) B Hospital Busan 7 Imported (Philippines) /Imported virus * Outbreak: cluster of more than two cases 5 Imported virus B days Imported virus B3 5.1 ongoing (6.28) 5M Imported virus B days 2M - 47 B days 11M - 33

17 Measles Outbreaks in other than Health Care Setting, in Korea, Jan-July 2014 Outbreak Name G Residence Academy H Middle school Region Cases No. Import State S. Gyeonggi (Kwangmyeog) Jeonnam (Mokpo) 9 Imported virus 15 Imported virus K Univ Seoul 85 Imported virus Genotype Setting Rash onset B3 Boarding school Duration Age range days B3 School days B3 University days G Company Chungnam 3 Imported D8 Office days B Upper school Seoul 17 Imported virus Y High school Seoul 4 Imported virus S High school Daegu 3 Imported (China) D High school Daegu 4 Imported (China) B3 School days B3 School days H1 School days H1 School 6.16 Ongoing (7.4) # Outbreaks in Korea, Jan-July 2014 Total 21 measles outbreaks Hospital(13), School(7), and Office(1) Average size: 12 cases [ranges, 3-85 cases] Average duration: 31 days [ranges, 3-58 days] * Outbreak: cluster of more than two cases

18 An Outbreak in K University and Catch Up Campaign 50 Cases Catch-up( ) Week

19 Summary of Surveillance Data of Measles Cases in Korea, Jan-July 2014 There are bimodal peaks; aged <1 year and aged years. The main outbreak settings were hospitals and schools. Significant proportion of measles cases in Korea, Jan-July 2014 was vaccinee (40.0%). Among 419 confirmed measles cases, there were 15 (3.6%) imported cases; 14 (93.9%) occurred in Korean residents returning from international travel, and 1 (6.1%) occurred in foreign visitor. Measles importation were associated with travel from 4 countries: the Philippines, China, Vietnam, and Singapore. Outbreak-related cases comprised 265 (63.2%) of total measles cases. Predominant measles genotype was B3.

20 Characteristics of the Recent Measles Outbreaks in Korea Continuous import from abroad Hospital infections among infants Outbreaks in previously vaccinated youth Overseas travels during vacations (students for language course in abroad, international students from abroad, multicultural families) Diagnosis failure due to atypical symptoms at the first visit to clinics Delayed notice of outbreaks after transmissions of several generations through hospitals, families, and schools Imports from abroad hospital infection through contacts to imported cases transmission among family members and in community transmission through infections at schools

21 Huge Outbreaks in Neighbor Countries WHO Measles-Rubella Bulletin, Vol 8 Issue 6 (June 2014)

22 Continuous Imports from Abroad Huge outbreaks in neighbor countries transmission by travellers

23 2ndary Transmission in Children s Hospital (57.0%) Transmission routes of measles cases in 2013 Hospital Day care Family School Overseas travel Community Total (37.5%) Transmission routes of measles cases in 2014 as of Jul 18 Hospital Day care Family School Overseas travel Community Total

24 Decrease of Passive Immunity in infants 7% of neonates have no measles Ab, 90% of infants have no measles Ab at 6 months of age in USA J Infect Dis 2004;190:83, J Infect Dis 2007;196:1459 Measles Sero-positive Rates under 2 years olds in Korea Kim SS et al. Vaccine23(2004) Measles Sero-positive Rates In infants under 1 year old Kim KH, 2009

25 Atypical Measles Manifestations in Pts with Vaccination history 홍역발생상황평가 : 청소년 / 성인백신접종자중심집단적인홍역발생 Classic measles (F+R+3C) Typical measles rash Non-classic measles Vaccinated Unvaccinated * Unvaccinated cases were more likely to present classic manifestations of measles [OR=3.656 (p <0.000)](among 330 measles cases with available data). *Atypical mild measles clinical features & low measles incidence Difficulty in diagnosis Atypical rash of a recent measles case

26 Delayed Notice Lead Wide Transmission Early detection and notification from clinics are important for control Index case

27 Delayed Notice Lead Wide Transmission Early detection and notification from clinics are important for control Index case

28 Vaccine Failure : Primary vs 2ndary 22% Never 38% 1 dose 2 doses Unknown 31% 9% Reported measles cases, Jan-July 2014, KCDC * A study in USA ( )(n: 288) : unvaccinated : 200(69%), unknown : 58(20%), vaccinated : 30(10%) * A study in Japan ( )(n: 183) : unknown or unvaccinated : 146(80%), vaccinated : 37(20%)

29 Waning Immunity after Vaccination Vaccination Natural infection P.O.Viana et al. J C linimmunol 2010 Davidkin I et al. JID 2008:197

30 Secondary Vaccine Failure Measles Outbreak in a Vaccinated School Population: Epidemiology, Chains of Transmission and the Role of Vaccine Failures Nkowane et al. Am J Public Health 1987 Outbreak of measles among persons with prior evidence of immunity, New York A Limited Measles Outbreak in a Highly Vaccinated US Boarding School Rosen et al. CID 2014 Yeung et al. Pediatrics, 2005 In case the level of neutralizing Ab is not enough, measles infection is possible. The present neutralizing Ab can t prevent atypical measles. (continuum of clinical illness) JID 1990 Chen RT et al. Based on the large cohort study(n=763) in U.S., 8.9% of vaccinees at 7.4 years after 2-dose MMR have Ab level < 210mIU/mL (protective threshold). There was no difference between ethnic groups Haralambieva IH et al. Vaccine 2011 Genetic factors(hla class I, II genotype, SNP polymorphism) may determine the response to Measles containing vaccine Haralambieva IH et al Expert Rev. Vaccines 2013

31 Utility of PCR for Measles Case Confirmation Classification Clinical IgM IgG PCR Vaccine reaction Fever/Rash P P or N Positive and Sequence indicates vaccine strain Measles Meets CCD* P P or N Positive PCR can confirm IgM Secondary vaccine Failure CCD or Modified # P or N P Positive PCR can confirm case *=clinical case definition (CCD) Presented by Paul Rota, Meeting at Korea CDC, March #=modified or mild presentation does not meet CCD In patients with vaccination history, Mild symptoms IgM may be negative in acute serum Characterized by rapid and robust IgG response If a second serum sample collected 5-10 days later remains IgM negative, then the paired serum samples can be tested in a PRN assay or quantitative or semiquantitative IgG EIA CDC VPD Surveillance Manual, 6 th Edition, 2013 Measles: Chapter 7-9

32 Vaccination is the most important Protective Measure Vaccine effectiveness (2014) No. of Hospitalized No. of infected Incidence Total % With vaccination hx % No vaccination hx % No. of hospitalized : All the hospitalized patients during the infective period of the index case of a hospital in Kyeonggi province No. of Hospitalized No. of infected Incidence Total % With vaccination hx No vaccination hx % No. of hospitalized : All the hospitalized patients during the infective period of the index case at the same ward of a hospital in Daejeon city

33 Latest Data of Measles Vaccine Efficacy/Effectiveness * Measles vaccine efficacy: Proportion of Vaccinee with measles specific Ab level (protective threshold) 15 years later after vaccination : 91.1% (Vaccine, 2011) * Measles vaccine effectiveness: 1 st dose measles vaccine: 9-11mo: 77.0% (IQR, 62%-91%) 12mo: 92.5% (IQR, 84.8%-97.0%) 2 nd dose measles vaccine: 94.1% (IQR, 88.3%-98.3%) (JID, 2013)

34 Acknowledgements

국내소아무균성뇌막염의전국적발생양상 정해관박수경기모란이관 B3 3 [14], 1995 B3 7 [13,15], 1996 B1[13], A24 9[16], 1997 B5 Echo 30[17,18], [19] [1-4]. . - [10].

국내소아무균성뇌막염의전국적발생양상 정해관박수경기모란이관 B3 3 [14], 1995 B3 7 [13,15], 1996 B1[13], A24 9[16], 1997 B5 Echo 30[17,18], [19] [1-4]. . - [10]. 원저 국내소아무균성뇌막염의전국적발생양상 정해관박수경기모란이관 성균관대학교의과대학사회의학교실을지대학교의과대학예방의학교실 서울대학교의과대학예방의학교실동국대학교의과대학예방의학교실 [1-4] 서론 1994 B3 3 [14] 199 B3 7 [13] 199 B1[13] A24 9[1] B Echo 3[1718] 1998 [19] enterovirus adenovirus

More information

Quote. These are my principles. If you don t like them I have others. Groucho Marx

Quote. These are my principles. If you don t like them I have others. Groucho Marx Quote These are my principles. If you don t like them I have others. Groucho Marx Analysis of the Auckland 2014 Measles Outbreak Indicates that Adolescents and Young Adults could Benefit from Catch up

More information

FMD situation & Control Strategy in Korea

FMD situation & Control Strategy in Korea FMD situation & Control Strategy in Korea November 13 th 2014 Park Sungdae D.V.M. Veterinary Epidemiology Division Animal and Plant Quarantine Agency (QIA), Republic of Korea Contents 50 MILLION SEOUL

More information

Regional Variation Of Mortality Within 1 Year After Acute Myocardial Infarction And Factors Affecting Mortality

Regional Variation Of Mortality Within 1 Year After Acute Myocardial Infarction And Factors Affecting Mortality Regional Variation Of Mortality Within 1 Year After Acute Myocardial Infarction And Factors Affecting Mortality Hyun Joo Kim 1) ; Hack-Lyoung Kim 2) ; Jin Yong Lee 3),4) ; Sang Jun Eun 5) ; Sang Hyun Cho

More information

Measles: United States, January 1 through June 10, 2011

Measles: United States, January 1 through June 10, 2011 Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA

More information

Current status and strategies for hepatitis B control in Korea

Current status and strategies for hepatitis B control in Korea pissn 2287-2728 eissn 2287-285X Review Clinical and Molecular Hepatology 2017;23:205-211 Current status and strategies for hepatitis B control in Korea Eun Ju Cho 1, Sung Eun Kim 2, Ki Tae Suk 3, Jihyun

More information

Closing MR Immunity Gaps Experiences from the Regions Sri Lanka

Closing MR Immunity Gaps Experiences from the Regions Sri Lanka Closing MR Immunity Gaps Experiences from the Regions Sri Lanka Dr. Paba Palihawadana Chief Epidemiologist Epidemiology Unit Ministry of Health Sri Lanka Background of the National Immunization Programme

More information

NYS Trends in Vaccine Preventable Disease Control

NYS Trends in Vaccine Preventable Disease Control NYS Trends in Vaccine Preventable Disease Control Cindy Schulte, BSN, RN Bureau of Immunization 518-473-4437 crs01@health.state.ny.us 1 Objectives Participants will be able to identify disease outbreaks

More information

Outbreaks and control of swine influenza viruses in Korea

Outbreaks and control of swine influenza viruses in Korea Inception meeting of the OIE/JTF Project for Controlling Zoonoses in Asia under One Health Concept Outbreaks and control of swine influenza viruses in Korea Tokyo, Japan, 19-20, December 2013 Yeun-Kyung

More information

Measles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health

Measles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Measles Elimination in NZ Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Presentation Outline International background WHO requirements Overview of the measles situation

More information

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office. Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable

More information

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January

More information

Current status and strategies for the control of viral hepatitis A in Korea

Current status and strategies for the control of viral hepatitis A in Korea pissn 2287-2728 eissn 2287-285X Review Clinical and Molecular Hepatology 2017;23:196-204 Current status and strategies for the control of viral hepatitis A in Korea Eileen L. Yoon 1, Dong Hyun Sinn 2,

More information

New guidelines for the management of norovirus outbreaks in acute and community health and social care settings

New guidelines for the management of norovirus outbreaks in acute and community health and social care settings Volume 5 Number 47 Published on: 25 November 2011 Current News New guidelines for the management of norovirus outbreaks in acute and community health and social care settings Surveillance of haemolytic

More information

Towards the Achievement of GHSA 2024 s Overarching Targets

Towards the Achievement of GHSA 2024 s Overarching Targets 정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents

More information

Measles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief

Measles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief Measles Update March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief Colorado Department of Public Health and Environment Presenters have

More information

Measles Makes a Comeback Epidemiology and Laboratory Testing

Measles Makes a Comeback Epidemiology and Laboratory Testing Measles Makes a Comeback Epidemiology and Laboratory Testing Craig Conover, MD Illinois Department of Public Health 2/10/2015 Measles Epidemiology Year round endemic transmission of measles ended in the

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

Adverse Event GACVS. Global Advisory Committee on Vaccine Safety, 910 June 2005

Adverse Event GACVS. Global Advisory Committee on Vaccine Safety, 910 June 2005 Adverse Event The Committee considered the decision taken by the Government of Japan on 30 May 2005 to suspend routine vaccination with the mouse brainderived Japanese encephalitis (JE) vaccine currently

More information

Immunization-Preventable Outbreaks, Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014

Immunization-Preventable Outbreaks, Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014 Immunization-Preventable Outbreaks, 2014 Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014 Outbreaks to Cover Meningococcus group B Pertussis Mumps

More information

A Study on the Strategic Vitalization Plan of Korean Integrated Medical Tourism

A Study on the Strategic Vitalization Plan of Korean Integrated Medical Tourism J Korean Med. 2013;34(2):41-50 pissn 1010-0695 eissn 2288-3339 Original Article A Study on the Strategic Vitalization Plan of Korean Integrated Medical Tourism Kee-Tae Kweon 1, Hwa-Kyung Kim 2 1 1Department

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

Monitoring vaccine-preventable diseases is

Monitoring vaccine-preventable diseases is New South Wales annual vaccinepreventable disease report, 2013 Surveillance Report Alexander Rosewell, a Paula Spokes a and Robin Gilmour a Correspondence to Robin Gilmour (e-mail: rgilm@doh.health.nsw.gov.au).

More information

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594 Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%

More information

NSW Annual Vaccine-Preventable Disease Report, 2009

NSW Annual Vaccine-Preventable Disease Report, 2009 NSW Annual Vaccine-Preventable Disease Report, 29 Paula J. Spokes A,B and Robin E. Gilmour A A Communicable Diseases Branch, NSW Department of Health B Corresponding author. Email: pspok@doh.health.nsw.gov.au

More information

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7 VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,

More information

EPIDEMIOLOGY OF VACCINE-PREVENTABLE VIRAL INFECTIONS IN ABORIGINAL & TORRES STRAIT ISLANDER AUSTRALIANS

EPIDEMIOLOGY OF VACCINE-PREVENTABLE VIRAL INFECTIONS IN ABORIGINAL & TORRES STRAIT ISLANDER AUSTRALIANS EPIDEMIOLOGY OF VACCINE-PREVENTABLE VIRAL INFECTIONS IN ABORIGINAL & TORRES STRAIT ISLANDER AUSTRALIANS EMMA GOEMAN ADVANCED TRAINEE IN PAEDIATRIC INFECTIOUS DISEASES & MICROBIOLOGY Email: emma.goeman@health.nsw.gov.au

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Measles: It s a Small World After All

Measles: It s a Small World After All Measles: It s a Small World After All Jennifer Zipprich, PhD June 24th, 2015 Measles Outbreaks Around the World China is reporting > 50,000 suspect and confirmed measles cases in 2015 Germany has reported

More information

Measles 2015: What We Need to Know

Measles 2015: What We Need to Know Faculty Measles 2015: What We Need to Know Karen Landers, MD, FAAP Assistant State Health Officer Tuberculosis Control and Immunization Alabama Department of Public Health Produced by the Alabama Department

More information

Mathematical Modelling of Infectious Diseases. Raina MacIntyre

Mathematical Modelling of Infectious Diseases. Raina MacIntyre Mathematical Modelling of Infectious Diseases Raina MacIntyre A little bit of EBM is a dangerous thing Research question: Does smoking cause lung cancer? Answer: I couldn t find a meta-analysis or even

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts

Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts Anne Schuchat, MD RADM, US Public Health Service Assistant Surgeon General Director, National Center for Immunization

More information

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea pissn 2287-2728 eissn 2287-285X Original Article Clinical and Molecular Hepatology 214;2:162-167 Changes in the seroprevalence of IgG anti-hepatitis A virus between 21 and 213: experience at a single center

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

VACCINE PREVENTABLE DISEASE EPIDEMIOLOGY

VACCINE PREVENTABLE DISEASE EPIDEMIOLOGY VACCINE PREVENTABLE DISEASE EPIDEMIOLOGY The Twenty-Second Annual Massachusetts Immunization Action Partnership Pediatric Immunization Skills Building Conference October 12, 2017 Marija PopStefanija, MPH,

More information

Epidemiology and Regional Distribution of Pediatric Unintentional Emergency Injury in Korea from 2010 to 2011

Epidemiology and Regional Distribution of Pediatric Unintentional Emergency Injury in Korea from 2010 to 2011 ORIGINAL ARTICLE Pediatrics http://dx.doi.org/10.3346/jkms.2015.30.11.1625 J Korean Med Sci 2015; 30: 1625-1630 Epidemiology and Regional Distribution of Pediatric Unintentional Emergency Injury in Korea

More information

An ongoing large outbreak of measles in Merseyside, England, January to June 2012

An ongoing large outbreak of measles in Merseyside, England, January to June 2012 Rapid communications An ongoing large outbreak of measles in Merseyside, England, January to June 212 R Vivancos (roberto.vivancos@hpa.org.uk) 1, A Keenan 1, S Farmer 1, J Atkinson 1, E Coffey 2, E Dardamissis

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region Volume 8 Issue 8 ust 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 y 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

OF MEASLES ELIMINATION

OF MEASLES ELIMINATION GUIDELINES ON VERIFICATION OF MEASLES ELIMINATION IN THE WESTERN PACIFIC REGION 2013 GUIDELINES ON VERIFICATION OF MEASLES ELIMINATION IN THE WESTERN PACIFIC REGION WHO Library Cataloguing-in-Publication

More information

Global Measles and Rubella Update October 2018

Global Measles and Rubella Update October 2018 Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region Volume 8 Issue 9 tember 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ust 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

HEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE

HEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE December 11, 2018 To: Health Care Providers, Hospitals, Emergency Departments, Dental Providers, and Local Health Departments From: New York State Department of Health, Bureau of Immunization HEALTH ADVISORY:

More information

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health California 2010 Pertussis Epidemic Kathleen Winter, MPH Immunization Branch California Department of Public Health Overview Pertussis Background California Pertussis Epidemic Challenges and Success Ongoing

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region Volume 8 Issue 10 ober 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 30 tember 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

Immunizations are among the most cost effective and widely used public health interventions.

Immunizations are among the most cost effective and widely used public health interventions. Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean

More information

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update. April 2018 Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct

More information

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region, Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed

More information

World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 13 September 2007 ISSN

World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 13 September 2007 ISSN Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 13 September 2007 ISSN 1814 3601 Monitoring Measles Surveillance and Progress Towards

More information

VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS

VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS VACCINE-PREVENTABLE DISEASES (VPDS): CURRENT TRENDS Adult Immunization Conference April 10, 2018 Steve Fleming, EdM stephen.fleming@state.ma.us Presenter Disclosure Information I, Steve Fleming, have been

More information

Chapter 6: Measles. I. Disease description. II. Background

Chapter 6: Measles. I. Disease description. II. Background Chapter 6, Measles: 6 1 Chapter 6: Measles Mark Papania, MD, MPH; Melinda Wharton, MD, MPH; Susan Redd I. Disease description Measles is an acute viral illness caused by a virus in the family paramyxovirus,

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10% A report on the epidemiology of selected vaccine-preventable diseases in the European Region This report provides an overview of selected epidemiological characteristics of measles and rubella in the WHO

More information

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Nigeria Center for Disease Control Federal Ministry of Health Abuja July 2015 Outline 1. Measles disease 2. Progress towards

More information

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update November 2018 Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep

More information

It IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado

It IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado It IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado Panel: Robyn Espy, M.P.H, Marigny Klaber, M.Sc., Shannon Rowe,

More information

Surveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH

Surveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH Surveillance, Reporting and Control of Influenza and Pertussis Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH Disclosures The speaker has no financial interest or conflict

More information

Measles Elimination Dr. Suzanne Cotter 4 th National Immunisation Conference 2007

Measles Elimination Dr. Suzanne Cotter 4 th National Immunisation Conference 2007 Measles Elimination 2010 Dr. Suzanne Cotter 4 th National Immunisation Conference 2007 Measles Viral illness Highly infectious Human reservoir only Respiratory transmission Responsible for ~500,000 deaths

More information

MEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague:

MEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague: MEASLES HEALTH ALERT/ADVISORY Date: February 5, 2019 Dear Colleague: Details of situation: Five measles cases, four between the ages of 12 to 21 months, have been reported in three different counties within

More information

Steps toward Measles Eradication in Japan A report from Okinawa Prefecture

Steps toward Measles Eradication in Japan A report from Okinawa Prefecture Conferences and Lectures Steps toward Measles Eradication in Japan A report from Okinawa Prefecture JMAJ 53(1): 19 23, 2010 Kaoru ASHIMINE* 1 Okinawa, a Measles-endemic Prefecture in Japan In 1998 1999,

More information

2017 Vaccine Preventable Disease Summary

2017 Vaccine Preventable Disease Summary 2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed

More information

LEARNING FROM OUTBREAKS: SARS

LEARNING FROM OUTBREAKS: SARS LEARNING FROM OUTBREAKS: SARS IFIC - APECIH 2017 KATHRYN N. SUH, MD, FRCPC 29 SEPTEMBER 2017 www.ottawahospital.on.ca Affiliated with Affilié à SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Nov 2002 southern

More information

Measles Surveillance in the United States: An Overview

Measles Surveillance in the United States: An Overview SUPPLEMENT ARTICLE Measles Surveillance in the United States: An Overview Dalya Güriş, Rafael Harpaz, Susan B. Redd, Natalie J. Smith, a and Mark J. Papania National Immunization Program, Centers for Disease

More information

In the setting of measles elimination in the United States, the current measles case definition lacks specificity.

In the setting of measles elimination in the United States, the current measles case definition lacks specificity. 12-ID-07 Committee: Infectious Disease Title: Public Health Reporting and ational otification for Measles I. Statement of the Problem In the setting of measles elimination in the United States, the current

More information

Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea

Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea Jpn. J. Infect. Dis., 64, 297-303, 2011 Original Article Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea Young June Choe*, Heeyeon Cho, Kyung Min

More information

2016 Vaccine Preventable Disease Summary

2016 Vaccine Preventable Disease Summary 2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County

More information

5/13/2015 TODAY S TOPICS SURVEILLANCE, REPORTING AND CONTROL OF VACCINE PREVENTABLE DISEASES 2015

5/13/2015 TODAY S TOPICS SURVEILLANCE, REPORTING AND CONTROL OF VACCINE PREVENTABLE DISEASES 2015 SURVEILLANCE, REPORTING AND CONTROL OF VACCINE PREVENTABLE DISEASES 2015 20 th Annual Massachusetts Adult Immunization Conference April 14, 2015 Hillary Johnson, MHS Meagan Burns, MPH Epidemiologists Epidemiology

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Measles and Measles Vaccine

Measles and Measles Vaccine Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region Volume 9 Issue 1 uary 2015 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ember 2014, WHO Western Pacific Region Legend: No confirmed case With confirmed case No

More information

Update on the dengue situation in the Western Pacific Region

Update on the dengue situation in the Western Pacific Region Dengue Situation Update 448 23 September 214 Update on the dengue situation in the Western Pacific Region Northern Hemisphere Japan As of September 22, Ministry of Health, Labour and Welfare (MHLW), Japan,

More information

STARK COUNTY INFLUENZA SNAPSHOT, WEEK 15 Week ending 18 April, With updates through 04/26/2009.

STARK COUNTY INFLUENZA SNAPSHOT, WEEK 15 Week ending 18 April, With updates through 04/26/2009. STARK COUNTY INFLUENZA SNAPSHOT, WEEK 15 Week ending 18 April, 29. With updates through 4/26/29. During week 15, countywide, state and national indicators confirmed very low markers of seasonal influenza

More information

Communicable Disease Control and Vaccine Preventable Diseases/Update and Impact. Agenda

Communicable Disease Control and Vaccine Preventable Diseases/Update and Impact. Agenda Communicable Disease Control and Vaccine Preventable Diseases/Update and Impact Communicable Disease Control and Prevention Bureau (CDCP) Communicable Disease Epidemiology Section (CDEpi) Agenda Communicable

More information

Influenza Season and EV-D68 Update. Johnathan Ledbetter, MPH

Influenza Season and EV-D68 Update. Johnathan Ledbetter, MPH 2014-2015 Influenza Season and EV-D68 Update Johnathan Ledbetter, MPH 2014-2015 Influenza Season Influenza Reporting Individual cases are not reportable in the state of Texas Situations where influenza

More information

EPIDEMIOLOGY SURVEILLANCE REPORT NORTHEAST REGION FALL Namitha Reddy Regional Coordinator North/Central West Region NJDOH/EEOH/CDS

EPIDEMIOLOGY SURVEILLANCE REPORT NORTHEAST REGION FALL Namitha Reddy Regional Coordinator North/Central West Region NJDOH/EEOH/CDS EPIDEMIOLOGY SURVEILLANCE REPORT NORTHEAST REGION FALL 2014 Namitha Reddy Regional Coordinator North/Central West Region NJDOH/EEOH/CDS Overview Purpose/Objectives State and Regional Highlights Select

More information

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9

More information

Re-emergence of old viruses

Re-emergence of old viruses Re-emergence of old viruses Erin Mathes, MD Associate Professor of Dermatology and Pediatrics University of California, San Francisco American Academy of Dermatology Annual Meeting, February 2018 Disclosures

More information

Chapter 4. Antibody detection methods for laboratory confirmation of measles, rubella, and CRS

Chapter 4. Antibody detection methods for laboratory confirmation of measles, rubella, and CRS Chapter 4. Antibody detection methods for laboratory confirmation of measles, rubella, and CRS In this chapter: 4.1 Selection and comparison of EIAs for IgM detection 4.2 Interpretation of IgM results

More information

Vaccine Preventable Diseases in San Francisco. Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010

Vaccine Preventable Diseases in San Francisco. Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010 Vaccine Preventable Diseases in San Francisco Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010 Section Responsibilities Communicable Disease Control Unit (CDCU): Communicable

More information

Measles in Ireland, 2005

Measles in Ireland, 2005 Measles in Ireland, 2005 Key Points There were 93 measles notifications in 2005 The crude incidence rate of measles per 100,000 population in 2005 was 2.4 compared to 8.4 in 2004 and 14.6 in 2003 Of the

More information

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update 30 August 2013 Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update Alert and Response Operations International Health Regulations, Alert and Response and Epidemic

More information

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009 pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2012;44(1):11-24 Special Article http://dx.doi.org/10.4143/crt.2012.44.1.11 Open Access Cancer Statistics in Korea: Incidence, Mortality, Survival, and

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Measles Revised August 2014 Measles 1.0 Provincial Reporting Confirmed and probable cases of disease

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

MUMPS & MEASLES: WHAT WE VE LEARNED FROM RECENT OUTBREAKS

MUMPS & MEASLES: WHAT WE VE LEARNED FROM RECENT OUTBREAKS MUMPS & MEASLES: WHAT WE VE LEARNED FROM RECENT OUTBREAKS Scott Lindquist MD MPH State Epidemiologist Washington State Department of Health Washington Vaccine Update October 27, 2017 DISCLOSURES This activity

More information

Humidifier disinfectant lung injury, how do we approach the issues?

Humidifier disinfectant lung injury, how do we approach the issues? eissn: 2233-6567 Environmental Health and Toxicology Special Topic Humidifier disinfectant lung injury, how do we approach the issues? Open Access Volume: 31, Article ID: e2016019, 7 pages http://dx.doi.org/10.5620/eht.e2016019

More information

Closing MR Immunity Gaps Experiences from the Regions Italy Overview on a changed epidemiology

Closing MR Immunity Gaps Experiences from the Regions Italy Overview on a changed epidemiology Closing MR Immunity Gaps Experiences from the Regions Italy Overview on a changed epidemiology Stefania Iannazzo MD PhD Infectious Diseases and International Prophylaxis Unit Directorate General for Health

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery

O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Delivery CPHA 2016 Health Protection June 14, 2016 Authors Rosalie Tuchscherer, Saskatchewan Ministry of Health Jill Reedijk, British

More information

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 11 December 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 11 December 2006 ISSN BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 11 December

More information

Vaccine Preventable Diseases. Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013

Vaccine Preventable Diseases. Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013 Vaccine Preventable Diseases In Utah: 2013 Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013 VPD Overview H3N2v Influenza Seasonal Influenza Pertussis Haemophilus influenzae

More information

SURVEILLANCE, REPORTING AND CONTROL OF VACCINE-PREVENTABLE DISEASES: WORKING TOGETHER TO CONTROL THE SPREAD

SURVEILLANCE, REPORTING AND CONTROL OF VACCINE-PREVENTABLE DISEASES: WORKING TOGETHER TO CONTROL THE SPREAD SURVEILLANCE, REPORTING AND CONTROL OF VACCINE-PREVENTABLE DISEASES: WORKING TOGETHER TO CONTROL THE SPREAD Adult Immunization Conference April 10, 2018 Nancy Harrington nancy.harrington@dph.state.ma.us

More information

Population-Based Study of the Epidemiology of Herpes Zoster in Korea

Population-Based Study of the Epidemiology of Herpes Zoster in Korea ORIGINAL ARTICLE Dermatology http://dx.doi.org/10.3346/jkms.2014.29.12.1706 J Korean Med Sci 2014; 29: 1706-1710 Population-Based Study of the Epidemiology of Herpes Zoster in Korea You Jeong Kim, 1 Chang

More information

Adherence to Physical Activity Among Older Adults Using a Geographic Information System: Korean National Health and Nutrition Examinations Survey IV

Adherence to Physical Activity Among Older Adults Using a Geographic Information System: Korean National Health and Nutrition Examinations Survey IV ORIGINAL ARTICLE Adherence to Physical Activity Among Older Adults Using a Geographic Information System: Korean National Health and Nutrition Examinations Survey IV Hye-A Yeom 1,2, PhD, RN, Dukyoo Jung

More information

Measles Elimination: Successes and Challenges in Alaska

Measles Elimination: Successes and Challenges in Alaska Measles Elimination: Successes and Challenges in Alaska Rosalyn Singleton, MD, MPH State of Alaska, Section Epidemiology & Alaska Native Tribal Health Consortium www.nwcphp.org/hot-topics Measles in the

More information

Specific antibody titers against various infectious agents in polyspecific human immunoglobulin preparations

Specific antibody titers against various infectious agents in polyspecific human immunoglobulin preparations Specific antibody titers against various infectious agents in polyspecific human immunoglobulin preparations Global Bio Conference 2018 Hye-Kyung Cho Department of Pediatrics, Gachon University College

More information

Influenza : What is going on? How can Community Health Centers help their patients?

Influenza : What is going on? How can Community Health Centers help their patients? Influenza 2008-2009: What is going on? How can Community Health Centers help their patients? Beth Nivin Bureau of Communicable Diseases New York City Dept. of Health and Mental Hygiene By the end of this

More information

Summary of Methods. Figure 1: Vaccines have been very effective in reducing most vaccine-preventable diseases in Colorado.

Summary of Methods. Figure 1: Vaccines have been very effective in reducing most vaccine-preventable diseases in Colorado. The Children s Hospital March 2004 Marsha Anderson, MD James Todd, MD Vaccine-preventable Diseases in Colorado s Children, 2002 For More Information: The Children s Hospital Public Affairs Department 303-861-8555

More information

Clinical and epidemiological characteristics analysis of measles in Shenzhen, China from 2010 to 2016

Clinical and epidemiological characteristics analysis of measles in Shenzhen, China from 2010 to 2016 Clinical and epidemiological characteristics analysis of measles in Shenzhen, China from 2010 to 2016 The aim of this study is to explore the epidemiological trend, clinical characteristics and treatment

More information

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008 pissn 1598-2998 eissn 2005-9256 Cancer Res Treat. 2011;43(1):1-11 Special Article DOI 10.4143/crt.2011.43.1.1 Open Access Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

More information